Cheiny Shiau, PA-C

Cheiny Shiau practices at Third Street Surgery Center in Los Angeles, California.

Cheiny Shiau's NPI, 1477036895, was assigned on September 11, 2018.

Cheiny Shiau's primary practice is Third Street Surgery Center, at 420 East 3rd Street Suite 110, Los Angeles, CA 90013. The practice phone is (213) 617-9194.

Cheiny Shiau's primary practice is Third Street Surgery Center in Los Angeles, California. The medical group on file is Irradiance Medical Group Dermatology. Dmand AI also links Cheiny Shiau to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Cheiny Shiau practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Cheiny Shiau's primary specialty in the NPI Registry, under taxonomy code 363AM0700X.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis and skin discoloration among the conditions Cheiny Shiau treats.

CMS data shows 160 Medicare services from Cheiny Shiau across 5 procedure codes in 2024, for 106 Medicare patients. Medicare paid $8,271 for them. Every service was in an office.

CMS counts 106 Medicare patients who saw Cheiny Shiau in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 74% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Cheiny Shiau's median patient age at 45, with 55% women.

In 2024, Cheiny Shiau wrote 1,844 Medicare Part D claims for 331 patients. 71% of them were for generic drugs. CMS names the drug for 1,674 of them, across 34 drugs with 11 or more claims each, at $3,019,417 in total drug cost.

Cheiny Shiau accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 785 general payments to Cheiny Shiau from 21 drug and device companies from 2024 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Abbvie Inc. paid the most, $27,748.